Biocon Biologics is an independent company of Biocon along with its own management team, is using its strong scientific background as well as global scale and extensive experience in biopharmaceuticals, to create and produce a range of high-quality biosimilars to treat various chronic diseases for the global populace.
Biocon Biologics A Global Pioneer
Biocon pioneering spirit has paved the way for the development of biotechnology in India and we continue to employ the same spirit to find innovative ways to improve patient outcomes and ensure a better future. We strive to explore new ways of treating cancer, diabetes, and auto-immune diseases. Our R&D is focused on prevention, relief, and treatment. Our medications help millions of patients across more than 120 countries, giving them access to lifesaving therapies and relief.
Biocon Biologics strive to create health equity
Utilizing advanced therapy platforms Our 13,500+ staff mix science, heart, and imagination to provide the most effective solutions to healthcare.
Biocon Products
Biocon Biologics four global businesses comprise biosimilars, generics, research services and innovative biologics. They are the Biocon’s risk-balanced strategies supported by a flexible network of connections, a strong pipeline and an “emerging markets” focus. We’ve leveraged India’s advantage of unparalleled expertise in science and manufacturing, as well as cost-effective manufacturing to offer the highest quality, speed and scale. In making medicine more readily accessible to patients around the world We are working towards achieving health equity.
Healthy Growth in Long Term Net Sales
Positive results in Dec 23
Low Debt to Equity Ratio
In last year company give 18.19% return
Biocon Biologics Why On Radar @ 280
- Financial Trend Is Positive
- Valuation Is Attractive (230-600)
- Good Quality Stock
- Technically In Bullish Range
- Shareholding Pattern is Better
- Pledged Holdings 0.0%
Share Holding Biocon
How Invest In Stock Market?
| SwaingRaja CheckList | |||
| Sr.No. | Title | Marks Out Of 5 | Remark |
| 1 | Long Term Fundamental | 4 | Average Return |
| 2 | Trend | 4 | Positive |
| 3 | Value | 4 | Better |
| 4 | Quality | 4 | Better |
| 5 | Shareholding | 5 | Best |
